215 related articles for article (PubMed ID: 23696194)
21. Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women.
Karim R; Stanczyk FZ; Brinton RD; Rettberg J; Hodis HN; Mack WJ
J Clin Endocrinol Metab; 2015 Feb; 100(2):508-15. PubMed ID: 25405497
[TBL] [Abstract][Full Text] [Related]
22. Association between pre-diagnostic circulating adipokines and colorectal cancer and adenoma in the CLUE II cohort.
Marrone MT; Lu J; Visvanathan K; Joshu CE; Platz EA
Cancer Causes Control; 2021 Aug; 32(8):871-881. PubMed ID: 33999316
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
[TBL] [Abstract][Full Text] [Related]
25. Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study.
Yamaji T; Iwasaki M; Sawada N; Shimazu T; Inoue M; Tsugane S
PLoS One; 2020; 15(2):e0229005. PubMed ID: 32053666
[TBL] [Abstract][Full Text] [Related]
26. Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol.
Dashti SG; Simpson JA; Viallon V; Karahalios A; Moreno-Betancur M; Brasky T; Pan K; Rohan TE; Shadyab AH; Thomson CA; Wild RA; Wassertheil-Smoller S; Ho GYF; Strickler HD; English DR; Gunter MJ
Cancer Med; 2022 Feb; 11(4):1145-1159. PubMed ID: 35048536
[TBL] [Abstract][Full Text] [Related]
27. Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study.
Trabert B; Brinton LA; Anderson GL; Pfeiffer RM; Falk RT; Strickler HD; Sliesoraitis S; Kuller LH; Gass ML; Fuhrman BJ; Xu X; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):648-56. PubMed ID: 26908437
[TBL] [Abstract][Full Text] [Related]
28. Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index-Breast Cancer Association.
Schairer C; Fuhrman BJ; Boyd-Morin J; Genkinger JM; Gail MH; Hoover RN; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):105-13. PubMed ID: 26637268
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
30. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
Dossus L; Franceschi S; Biessy C; Navionis AS; Travis RC; Weiderpass E; Scalbert A; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bonnet F; Fournier A; Fortner RT; Kaaks R; Aleksandrova K; Trichopoulou A; La Vecchia C; Peppa E; Tumino R; Panico S; Palli D; Agnoli C; Vineis P; Bueno-de-Mesquita HBA; Peeters PH; Skeie G; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sánchez MJ; Ramón Quirós J; Dorronsoro M; Sandström M; Nilsson LM; Schmidt JA; Khaw KT; Tsilidis KK; Aune D; Riboli E; Rinaldi S
Int J Cancer; 2018 Apr; 142(7):1332-1342. PubMed ID: 29168186
[TBL] [Abstract][Full Text] [Related]
31. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
Brown SB; Hankinson SE
Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
[TBL] [Abstract][Full Text] [Related]
32. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
33. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.
White DL; Hoogeveen RC; Chen L; Richardson P; Ravishankar M; Shah P; Tinker L; Rohan T; Whitsel EA; El-Serag HB; Jiao L
Cancer Med; 2018 May; 7(5):2180-2191. PubMed ID: 29573228
[TBL] [Abstract][Full Text] [Related]
35. Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer.
Zhu X; Liu L; Feng Z; Zhang Y
J Obstet Gynaecol; 2023 Dec; 43(1):2179914. PubMed ID: 36815556
[TBL] [Abstract][Full Text] [Related]
36. Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.
Sherman ME; Madigan MP; Lacey JV; Garcia-Closas M; Potischman N; Carreon JD; Hartge P; Brinton LA
Gynecol Oncol; 2007 Dec; 107(3):431-5. PubMed ID: 17720234
[TBL] [Abstract][Full Text] [Related]
37. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
[TBL] [Abstract][Full Text] [Related]
38. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study.
Song M; Zhang X; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2013 Sep; 6(9):875-85. PubMed ID: 23872505
[TBL] [Abstract][Full Text] [Related]
39. Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.
Kabat GC; Kim MY; Lane DS; Zaslavsky O; Ho GYF; Luo J; Nicholson WK; Chlebowski RT; Barrington WE; Vitolins MZ; Lin X; Liu S; Rohan TE
Eur J Cancer Prev; 2018 May; 27(3):261-268. PubMed ID: 29438162
[TBL] [Abstract][Full Text] [Related]
40. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.
Catsburg C; Gunter MJ; Chen C; Cote ML; Kabat GC; Nassir R; Tinker L; Wactawski-Wende J; Page DL; Rohan TE
Cancer Res; 2014 Jun; 74(12):3248-58. PubMed ID: 24755474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
